期刊文献+

白杨素对人肝癌HepG2细胞的诱导分化作用 被引量:7

Differentiation of HepG 2 cell induced by chrysin
下载PDF
导出
摘要 目的:探讨白杨素对人肝癌HepG2细胞的诱导分化和凋亡作用。方法体外培养人肝癌HepG2细胞,以全反式维甲酸为阳性对照,用白杨素干预细胞,台盼蓝计数法和MTT法检测药物对细胞增殖活力的影响;瑞氏-姬姆萨和考马斯亮蓝染色观察细胞核质比和微管微丝排列的变化;放射免疫法检测细胞甲胎蛋白(Alpha-fetoprotein,AFP)的分泌量;酶促反应试剂盒检测细胞中γ-谷胺酰转肽酶(γ-glutamyltranspeptidase,γ-GT)和碱性磷酸酶(alkaline phosephatase,ALP)的活性;Diamondstone分光光度法测定细胞中酪氨酸α-酮戊二酸转氨酶(tyrosine-α-ketoglutaric acid transaminase,TAT)的合成情况。结果1~100μmol/L白杨素和全反式维甲酸处理HepG2细胞48 h后,能显著抑制肝癌细胞的增殖(P<0.05,P<0.01),2种药物对细胞增殖的抑制效价相当并存在量效关系。10μmol/L药物作用48 h,细胞的形态和微管微丝排列由肿瘤细胞向成熟细胞分化;药物处理24~96 h后,细胞AFP的分泌量和γ-GT的活性明显降低,ALP和TAT的活性则显著升高(P<0.05,P<0.01)。结论白杨素具有抑制人肝癌HepG2细胞增殖并诱导其向正常细胞分化的作用。 Objective To investigate the effects of chrysin(ChR) on the induction of differentiation and apoptosis-promoting of HepG 2 human primary hepatocacinoma cells. Methods The HepG 2 cells were cultured in vitro, and then treated with ChR and all-trans retinotic Acid (RA), respectively, the alterations of nucleocytoplasm and tubulin arrangement after Gimsa staining and Coomassie brilliant blue staining were observed. The survival rate and the inhibitory rates of HepG 2 cells were determine by trypan blue counting method and MTT assay. The Alpha-fetoprotein(AFP) secretory amounts of the cells were detected by radioimmunoassay(RIA). The activities of alkaline phosphatase(ALP) andγ-glutamyltranspeptidase(γ-GT) were assayed by enzymatic reaction kit. The synthesis of tyrosine-α-ketoglutaric acid transaminase(TAT) in cells were investigated by Diamondstone spectrophotometry. Results After treatment with ChR or RA at 1.0~100μmol/L for 48 h, the proliferation of HepG 2 cells were inhibited significantly, compared with vehicle group (P<0.05 or P<0.01), the inhibitory potency of both ChR and RA on HepG 2 cells was equivalent and indicated in dose-dependent manner. After treatment with 10μmol/L ChR or RA for 48 h, HepG 2 cells disaggregated and grew to spindle-shape, their nuclei became smaller and the number of nucleolus were fewer. Furthermore, tubulin arrangement of cells tended to be more ordered and the tubulin synthesis increased significantly. At 24~96 hours treated with 10μmol/L ChR, the activities of TAT and ALP in cells were all increased distinctly (P<0.05, P<0.01), and the secretory amounts of AFP and the specific activities ofγ-GT were decreased significantly (P<0.05, P<0.01). Conclusion Chrysin can inhibit the proliferation of HepG 2 cells and induce them to differentiate to mature cells.
出处 《中国生化药物杂志》 CAS 北大核心 2014年第2期33-36,共4页 Chinese Journal of Biochemical Pharmaceutics
基金 湖南省自然科学基金(06JJ 30016) 衡阳市科技局项目(2009KJ09)
关键词 白杨素 HEPG2细胞 细胞分化 黄酮类化合物 chrysin HepG 2 cells cell differentiation lfavonoid compounds
  • 相关文献

参考文献7

二级参考文献70

共引文献37

同被引文献80

  • 1许晓婷,翟明胜,蒋金航,陈晓佩,丁丹丹,于文浩,刘远哲,王新庄.DMSO对兔骨髓间充质干细胞诱导分化为胰岛细胞的影响[J].中国兽医学报,2015,35(1):97-102. 被引量:3
  • 2张婷,陈晓岚,屈凌波,董文杰,赵玉芬,吴梧桐.白杨素和它的四乙基二磷酸酯对人宫颈癌Hela细胞增殖和核基质蛋白影响的研究[J].药物生物技术,2005,12(5):312-316. 被引量:3
  • 3邓其跃,李淑蓉,蔡文琴,苏炳银.不同组织膜蛋白及二甲基亚砜对小脑颗粒细胞突起生长的影响[J].第三军医大学学报,2006,28(3):189-191. 被引量:3
  • 4孙华斌,马广鹏.辐射防护剂DMSO、As_2O_3及其作为肿瘤诱导分化剂、凋亡剂的研究[J].中国辐射卫生,2007,16(1):12-14. 被引量:3
  • 5Karp J E,Garrett-Mayer E,Estey E H,et al.Randomized phaseⅡstudy of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed,poor-risk acute myelogenous leukemia[J] .Haematologica,2012,97(11):1736-1742.
  • 6Bose P,Perkins E B,Honeycut C,et al.PhaseⅠtrial of the combination of flavopiridol and imatinib mesylate in patients with BcrAbl+hematological malignancies[J] .Cancer Chemother Pharmacol,2012,69(6):1657-1667.
  • 7Woyach J A,Lozanski G,Ruppert A S,et al.Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol:impact of genetic features[J] .Leukemia,2012,26(6):1442-1444.
  • 8Stephens D M,Ruppert A S,Blum K,et al.Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach[J] .Haematologica,2012,97(3):423-427.
  • 9Karp J E,Smith B D,Resar L S,et al.Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias[J] .Blood,2011,117(12):3302-3310.
  • 10Masayuki N,Kaori T,Yuzo T,et al.Increased bioavailability of rricin-amino acid derivatives via a prodrug approach[J] .J Med Chem,2011,54(5):1529-1536.

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部